Medical News

RSS

Ensign acquires real estate assets of Orem Rehabilitation & Nursing Center

The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Orem Rehabilitation & Nursing Center, a 108-bed skilled nursing facility in Orem, Utah.

4 Jan 2012

FDA approves CSL Behring's Berinert for treatment of HAE attacks

CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for self-administration of Berinert, C1 Esterase Inhibitor (Human), a pasteurized, nanofiltered therapy indicated for the treatment of acute attacks of hereditary angioedema (HAE), a rare and potentially fatal genetic disorder.

4 Jan 2012

Bionovo enters $5M securities purchase agreement with Socius

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.

4 Jan 2012

As the health law goes on trial, Supreme Court justices' recusal questions continue to grab headlines

While the Wall Street Journal takes a look at how the individual mandate could be viewed by specific justices, news services report on the chief justice's view of the health care recusal issue.

4 Jan 2012

BioLineRx commences BCM CE Mark registration trial for prevention of cardiac remodeling following AMI

BioLineRx, a biopharmaceutical development company, announced today the commencement of the PRESERVATION I clinical trial, a CE Mark registration trial of BCM (BL-1040), a novel medical device intended for the prevention of cardiac remodeling following an acute myocardial infarction (AMI).

4 Jan 2012

Quest Diagnostics to acquire S.E.D. Medical Labs

S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated, the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.

From Quest Diagnostics 4 Jan 2012

Neogen develops new Reveal Q+ test for deoxynivalenol

Neogen Corporation has developed a new test for deoxynivalenol (DON) that combines the speed and simplicity of a lateral flow test with the fully quantitative precision of a more demanding testing method.

4 Jan 2012

FDA approves Cyberonics re-designed AspireHC generator

Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.

4 Jan 2012

Arena, Eisai collaborate in response to FDA's lorcaserin Complete Response Letter

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that Arena has submitted its response to the Complete Response Letter (CRL) issued by the US Food and Drug Administration (FDA) following review of the lorcaserin New Drug Application (NDA).

4 Jan 2012

State roundup: Texas health assistance program closing; Florida's dangerous assisted living facilities

A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.

4 Jan 2012

$Yakult Honsha commences perifosine Phase 1/2 trial for refractory advanced colorectal cancer in Japan$

Yakult Honsha commences perifosine Phase 1/2 trial for refractory advanced colorectal cancer in Japan

Aeterna Zentaris Inc. today announced that its Japanese partner, Yakult Honsha, has initiated a Phase 1/2 trial in Japan to assess the safety and efficacy of the Company's PI3K/Akt inhibitor, perifosine, in combination with chemotherapeutic agent, capecitabine, in patients with refractory advanced colorectal cancer ("CRC").

4 Jan 2012

Woman's ovarian cycle plays an important role in her susceptibility to infection

A new research report in the Journal of Leukocyte Biology suggests that a woman's ovarian cycle plays an important role in her susceptibility to infection.

4 Jan 2012

Landec second quarter revenues increase 16% to $81.6 million

Landec Corporation, today reported results for the second quarter and first half of fiscal year 2012. Revenues for the second quarter of fiscal year 2012 increased 16% to $81.6 million compared to revenues of $70.2 million for the second quarter of fiscal year 2011.

4 Jan 2012

CMS assigns J-code for Eisai's Halaven Injection to treat breast cancer

Eisai Inc. announced today that the Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPCS) J-code for Halaven (eribulin mesylate) Injection.

4 Jan 2012

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange announced today the successful results of the Phase 1/2 study of its drug candidate CF102 in the treatment of hepatocellular carcinoma.

4 Jan 2012

Viewpoints: Giving states responsibility for 'essential benefits'; The cost of proton beam treatment; Health spending in 2012

The Obama administration surprised supporters and critics when it decided to let states define the "essential health benefits" that must be provided to their citizens under health care reform. ... Federal health officials will need to monitor developments during the transition period to make sure consumers and employers can easily compare the benefit packages offered by private insurers.

3 Jan 2012

AAPHC chooses eClinicalWorks comprehensive EHR solution

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that Albany Area Primary Health Care (AAPHC), the largest primary physician practice in Southwest Georgia and a Community Health Center (CHC), has chosen eClinicalWorks comprehensive electronic health records (EHR) solution across its 14 locations. According to figures by the NACHC, eClinicalWorks customers represent 33% of CHCs in the country.

3 Jan 2012

iCAD enters $15M debt facility agreement with Deerfield Management

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it has entered into a five year, $15 million debt facility agreement with Deerfield Management Company LP, a leading healthcare investment fund.

3 Jan 2012

HP, GlobalMed partner to launch tablet PC, three new mobile telemedicine carts

GlobalMed today announced it is partnering with HP to introduce three new mobile telemedicine carts and a tablet PC solution powered by HP Workstations and EliteBook PCs that will bring doctors and patients together for clinical healthcare at a distance.

3 Jan 2012

Origin of osteoporosis could be directly linked to manganese depletion

The loss of manganese could mean that calcium does not stick to bones and could cause osteoporosis. This is the new theory put forward by researchers at the University of Castilla-La Mancha (UCLM) in Spain after studying deer antlers.

3 Jan 2012